IHS Chemical Week

Regions :: Western Europe

BASF extends offer period for the acquisition of Pronova BioPharma

7:54 AM MST | December 19, 2012 | Sotirios Frantzanas

BASF says it is extending, until 18 January 2013, the offer period for the company's acquisition of all of the issued and outstanding shares of Pronova BioPharma (Lysaker, Norway)—a pioneer in the fields of researching, developing, and manufacturing omega-3 fatty acids—for 12.50 Norwegian krone/share ($2.25), or NK4.84 billion, in cash. The offer remains subject to the terms and conditions set out in the initial voluntary public takeover offer document, published on 5 December 2012.  The offer is conditional on BASF...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa